CompletedNot Applicable

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Belgium50 participantsStarted 2020-06-09

Plain-language summary

SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called "Acute Respiratory Distress Syndrome". The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility. This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.

Who can participate

Age range90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Be over 90 years of age on the date of admission to CHU Brugmann Hospital * Have a SARS Cov2 infection proven by antigen or RT-PCR on smear and / or typical imaging regardless of the clinical manifestation * Have been hospitalized at CHU Brugmann between 03/01/2020 and 05/10/2020 Exclusion Criteria: None

What they're measuring

Demographic data

Timeframe: 5 minutes

Comorbidities

Timeframe: 5 minutes

Cumulative Illness Rating Scale-Geriatric (CIRS-G)

Timeframe: 5 minutes

Treatments

Timeframe: 5 minutes

Signs and symptoms

Timeframe: 5 minutes

Fever

Timeframe: 5 minutes

Hypoxemia

Timeframe: 5 minutes

Tachycardia

Timeframe: 5 minutes

Hypotension

Timeframe: 5 minutes

Trial details

NCT IDNCT04499300

SponsorMurielle Surquin

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-11-23

View on ClinicalTrials.gov More Covid19 trials